Fatty acid-sensitive two-pore domain K+ channels

Trends in Pharmacological Sciences

Volumn 24, Issue 12, 2003, Pages 648-654

  Kim, Donghee ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; HALOTHANE; INHALATION ANESTHETIC AGENT; NEUROTRANSMITTER; POTASSIUM CHANNEL; POTASSIUM CHANNEL PROTEIN TREK 1; POTASSIUM CHANNEL PROTEIN TREK-1; RILUZOLE; TRAAK CHANNEL; TREK 2 CHANNEL; TREK-2 CHANNEL; UNCLASSIFIED DRUG;

ANIMAL; BINDING AFFINITY; CELL PH; CELL SWELLING; CENTRAL NERVOUS SYSTEM; HUMAN; METABOLISM; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0345118935     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.10.008     Document Type: Review

References (54)

1. Kim D., Clapham D.E. Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science. 244:1989;1174-1176.
2. + channels in cardiac myocytes by free fatty acids. Circ. Res. 67:1990;1040-1046.
3. Ordway R.W., et al. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science. 244:1989;1176-1179.
4. + channel activity in smooth muscle cells. Effects of fatty acids, lysophosphatidate, acyl coenzyme A and sphingosine. J. Gen. Physiol. 103:1994;471-486.
5. + channels in cultured rat neuronal cells. J. Physiol. 484:1995;643-660.
6. Han J., et al. Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus. J. Physiol. 546:2003;625-639.
7. + channel in heart cells: activation by arachidonic acid. J. Gen. Physiol. 100:1992;1-20.
8. Sukharev S.I., et al. Mechanosensitive channels of Escherichia coli: the MscL gene, protein, and activities. Annu. Rev. Physiol. 59:1997;633-657.
9. Ketchum K.A., et al. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature. 376:1995;690-695.
10. Goldstein S.N., et al. ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 93:1996;13256-13261.
11. + channel with a novel structure. EMBO J. 15:1996;1004-1011.
12. 2+ dependency. EMBO J. 16:1997;2565-2575.
13. Wei A., et al. Eight potassium channel families revealed by the C. elegans Genome project. Neuropharmacology. 35:1996;805-829.
14. Chavez R.A., et al. TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family. J. Biol. Chem. 274:1999;7887-7892.
15. + channel principal subunit. FEBS Lett. 450:1999;191-196.
16. + channel to sense external pH variations near physiological pH. EMBO J. 16:1997;5464-5471.
17. + channel (cTBAK). Circ. Res. 82:1998;513-518.
18. + channel family. J. Biol. Chem. 275:2000;9340-9347.
19. + channel. EMBO J. 15:1996;6854-6862.
20. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 17:1998;3297-3308.
21. + channel family. J. Biol. Chem. 275:2000;17412-17419.
22. + channels. J. Biol. Chem. 276:2001;7302-7311.
23. + channels. Biochem. Biophys. Res. Commun. 282:2001;249-256.
24. + channel, TRESK, is localized in the spinal cord. J. Biol. Chem. 278:2003;27406-27412.
25. Maingret F., et al. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J. Biol. Chem. 274:1999;26691-26696.
26. + channel. J. Biol. Chem. 274:1999;1381-1387.
27. + channel. EMBO J. 17:1998;4283-4290.
28. Kim Y., et al. Synergistic Interaction and the Role of C-Terminus in the Activation of TRAAK K+ Channels by Pressure, Free Fatty Acids and Alkali. Pflugers Arch. 442:2001;64-72.
29. + channel signature sequence. Biophys. J. 66:1994;1061-1067.
30. + conduction and selectivity. Science. 280:1998;69-77.
31. + channel. Nature. 423:2003;33-41.
32. Medhurst A.D., et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res. Mol. Brain Res. 86:2001;101-114.
33. Talley E.M., et al. CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21:2001;7491-7505.
34. Bockenhauer D., et al. KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat. Neurosci. 4:2001;486-491.
35. Gu W., et al. Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J. Physiol. 539:2002;657-668.
36. + channel gene KCNK4. Chromosomal localization, tissue distribution and functional expression. Brain Res. Mol. Brain Res. 102:2002;18-27.
37. Han J., et al. Characterization of four types of background potassium channels in rat cerebellar granule neurons. J. Physiol. 542:2002;431-444.
38. + channel in cultured rat brain astrocytes. Brain Res. 931:2002;56-67.
39. Patel A.J., et al. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat. Neurosci. 2:1999;422-426.
40. Nicoll R.A., Madison D.V. General anesthetics hyperpolarize neurons in the vertebrate central nervous system. Science. 217:1982;1055-1057.
41. A and glycine receptors. Nature. 389:1997;385-389.
42. + channel is a molecular substrate for neuronal effects of inhalation anesthetics. J. Neurosci. 20:2000;6347-6354.
43. Talley E.M., Bayliss D.A. Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels. Volatile anesthetics and neurotransmitters share a molecular site of action. J. Biol. Chem. 277:2002;17733-17742.
44. Punke M.A., et al. Inhibition of human TREK-1 channels by bupivacaine. Anesth. Analg. 96:2003;1665-1673.
45. + channels TREK-1 and TRAAK. Mol. Pharmacol. 57:2000;906-912.
46. Meadows H.J., et al. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. Brain Res. 892:2001;94-101.
47. Lauritzen I., et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 19:2000;1784-1793.
48. + channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch. 442:2001;952-960.
49. + channel TREK-1. EMBO J. 21:2002;2968-2976.
50. + channel. EMBO J. 17:1998;4283-4290.
51. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J. Biol. Chem. 275:2000;28398-28405.
52. Koh S.D., et al. TREK-1 Regulation by Nitric Oxide and cGMP-dependent Protein Kinase. An essential role in smooth muscle inhibitory neurotransmission. J. Biol. Chem. 276:2001;44338-44346.
53. Bazan N.G., et al. Role of phospholipase A2 and membrane-derived lipid second messengers in membrane function and transcriptional activation of genes: implications in cerebral ischemia and neuronal excitability. Prog. Brain Res. 96:1993;247-257.
54. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.